Overview Biohaven is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. We are advancing our innovative portfolio of therapeutics, leveraging our proven drug development experience and multiple proprietary drug development platforms. On October 3, 2022, Biohaven Pharmaceutical Holding Company Ltd. (the Former Parent) completed the distribution to holders o...
Q2 FY2026 — expected 2026-08-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001935979-26-000020 | EDGAR | 103K words |
| 2025-03-03 | 2024-12-31 | 0001935979-25-000015 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001935979-24-000010 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0001935979-23-000009 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001935979-25-000092 | EDGAR | 35K words |
| 2025-08-11 | 2025-06-30 | 0001935979-25-000068 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001935979-25-000054 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001935979-24-000085 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001935979-24-000069 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001935979-24-000046 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001935979-23-000062 | EDGAR | — |
| 2023-07-31 | 2023-06-30 | 0001935979-23-000052 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001935979-23-000029 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001935979-22-000011 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-02 | 0001935979-26-000022 | EDGAR | 7K words |
| 2026-01-12 | 0001935979-26-000005 | EDGAR | — |
| 2026-01-07 | 0001935979-26-000002 | EDGAR | — |
| 2025-11-13 | 0001628280-25-052066 | EDGAR | — |
| 2025-11-10 | 0001935979-25-000090 | EDGAR | — |
| 2025-08-22 | 0001935979-25-000080 | EDGAR | — |
| 2025-08-15 | 0001935979-25-000074 | EDGAR | — |
| 2025-08-11 | 0001935979-25-000067 | EDGAR | — |
| 2025-06-04 | 0001935979-25-000058 | EDGAR | — |
| 2025-05-15 | 0001935979-25-000056 | EDGAR | — |
74 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001935979 |
| Ticker | BHVN |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | D8 |
| Website | https://www.biohaven.com |
| Listed | 2022-09-23 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report